KNC Laboratories Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 340

Employees

  • Stock Symbol
  • 6568

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $7.44
  • (As of Thursday Closing)

KNC Laboratories General Information

Description

KNC Laboratories Co Ltd is an organic chemical and biochemical manufacturing company.

Contact Information

Website
www.kncweb.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 7-1-19 Minatojimaminamimachi
  • Chuo-ku
  • Kobe, Hyogo 650-0047
  • Japan
+81
Primary Industry
Multi-line Chemicals
Stock Exchange
TKS
Vertical(s)
Manufacturing
Corporate Office
  • 7-1-19 Minatojimaminamimachi
  • Chuo-ku
  • Kobe, Hyogo 650-0047
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KNC Laboratories Stock Performance

As of 12-Nov-2026, KNC Laboratories’s stock price is $7.44. Its current market cap is $57.6M with 7.74M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.44 $7.41 $6.80 - $8.97 $57.6M 7.74M 3.96K $0.69

KNC Laboratories Financials Summary

As of 30-Jun-2026, KNC Laboratories has a trailing 12-month revenue of $61.6M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 71,416 72,956 55,802 71,158
Revenue 61,632 60,333 53,633 63,358
EBITDA 15,193 11,969 20,935
Net Income 5,301 5,083 4,835 10,333
Total Assets 130,226 135,396 134,671 123,037
Total Debt 20,498 22,499 20,843 13,017
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KNC Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KNC Laboratories‘s full profile, request access.

Request a free trial

KNC Laboratories Patents

  • 212

    Total Documents Applications and Grants

  • Total Patents Families

  • 95

    Granted

  • 33

    Pending

  • Expiring in next 12 mo

KNC Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026034442-A1 Oligonucleotide for controlling liquid-liquid phase separation Pending 05-Aug-2024
EP-4599833-A1 Pharmaceutical composition containing zinc polyphosphate Pending 27-Oct-2022
EP-4599833-A4 Pharmaceutical composition containing zinc polyphosphate Pending 27-Oct-2022
US-20260166076-A1 Pharmaceutical composition containing zinc polyphosphate Pending 27-Oct-2022
WO-2024090538-A1 Pharmaceutical composition containing zinc polyphosphate Inactive 27-Oct-2022 A61K33/42
To view KNC Laboratories’s complete patent history, request access »

KNC Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KNC Laboratories Investments & Acquisitions (6)

KNC Laboratories’s most recent deal was a Later Stage VC with Immunorock for . The deal was made on 03-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunorock 03-Feb-2026 Later Stage VC Drug Discovery
NapaJen Pharma 18-Mar-2024 Secondary Transaction - Private Drug Discovery
J-Pharma 11-Aug-2021 Later Stage VC Drug Discovery
Okami Pharmaceutical (Taicang) 01-Oct-2007 Merger/Acquisition Buildings and Property
Ohshin Pharmaceutical (Taicang) 01-Oct-2003 Joint Venture Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

KNC Laboratories ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view KNC Laboratories’s complete esg history, request access »

KNC Laboratories Exits (3)

KNC Laboratories’s most recent exit was on 11-Aug-2021 from J-Pharma. The exit was categorized as with 22 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
J-Pharma 11-Aug-2021 Completed
  • 22 buyers
Okami Pharmaceutical (Taicang) 01-Oct-2007 Completed
Daiichi Kasei 01-Jun-2003 Merger/Acquisition Completed
To view KNC Laboratories’s complete exits history, request access »

KNC Laboratories FAQs

  • When was KNC Laboratories founded?

    KNC Laboratories was founded in 1985.

  • Where is KNC Laboratories headquartered?

    KNC Laboratories is headquartered in Kobe, Japan.

  • What is the size of KNC Laboratories?

    KNC Laboratories has 340 total employees.

  • What industry is KNC Laboratories in?

    KNC Laboratories’s primary industry is Multi-line Chemicals.

  • Is KNC Laboratories a private or public company?

    KNC Laboratories is a Public company.

  • What is KNC Laboratories’s stock symbol?

    The ticker symbol for KNC Laboratories is 6568.

  • What is the current stock price of KNC Laboratories?

    As of 12-Nov-2026 the stock price of KNC Laboratories is $7.44.

  • What is the current market cap of KNC Laboratories?

    The current market capitalization of KNC Laboratories is $57.6M.

  • What is KNC Laboratories’s current revenue?

    The trailing twelve month revenue for KNC Laboratories is $61.6M.

  • What is KNC Laboratories’s annual earnings per share (EPS)?

    KNC Laboratories’s EPS for 12 months was $0.69.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process